PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

New Directions in Marketing: A Pharm Exec Resource

Funding Shortfalls Hinder Zika Vaccine Development

Compliance in the 21st Century: Pharm Exec's New eBook

Top Story

Opioid Epidemic: More Finger Pointing at the Industry

Traditional sales and pricing practices face legal challenges and political backlash, writes Jill Wechsler
... /Read more/

Learn how pharma is using data science-driven suggestions to elevate the customer experience and drive sales force effectiveness.

Read the article

Compliance

Sunshine Data Helps Feds Uncover Fraud

$7.5 billion in pharma “transfers of value” made in 2015 has caught the attention of the DoJ and federal and state prosecutors investigating fraud
... /Read more/

Technology can't replace people–why Patient Support Programs need a personal approach
Live Webcast: Thursday, September 29 at 8:00 EDT

Regulatory

The 'Cure'–All for 21st Century Data Sharing

Balancing today's health data demands and patient privacy is not about new regulations—it's taking a risk-based approach, writes Pamela Neely Buffone
... /Read more/

Breaking the Circle of Distrust with a Radical PLC Pricing Model
On Demand

Learn more

Europe

Challenges for the New Innovative Medicines Initiative

Europe's Innovative Medicines Initiative (IMI) still has a lot to prove, and the climate is not entirely favorable, writes Reflector. What are the obstacles ahead for the revamped scheme?
... /Read more/

Calendar

/ September 15–16: Compliance Congress for Specialty Products /

Boston, MA

/ October 5: Drug, Chemical & Associated Technology Association (DCAT) After the Show /

Barcelona, Spain

/ October 27–28: MedComm 2016 /

San Francisco, CA

/ December 13–14: Life Sciences Trade and Channel Strategies /

Philadelphia, PA

/ February 22–23, 2017: Speaker Programs 2017 /

Philadelphia, PA

Best Practices for Integrating Biomarkers across the Drug Development Continuum
On Demand

Learn more

Industry update

//Hemispherx Biopharma (Philadelphia, PA) announced that it has formed a Scientific Advisory Board. The Board consists of William Mitchell, M.D., Ph.D., Ronald Brus, M.D., W. Neal Burnette, Ph.D., and Christopher Nicodemus, M.D., F.A.C.P.//Retrophin, Inc. (San Diego, CA) announced that Neil McFarlane has been appointed Chief Operating Officer.//Seno Medical Instruments (San Antonio, TX) appointed Tammy Garcia as Senior Vice President of Sales & Marketing.//

advertise with us / print subscribe / digital subscribe / visit pharmexec.com